Skip to main content
Glenn Liu, MD, Oncology, Madison, WI, University Hospital

GlennLiuMD

Oncology • Madison, WI

Genitourinary Oncology

Professor of Medicine and Medical Physics, University of Wisconsin School of Medicine and Public Health School

Join to view full profile

Dr. Liu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Liu's full profile

Already have an account?

Summary

  • Glenn Liu, MD is a Professor of Medicine and Medical Physics at the University of Wisconsin. He is the Head of Genitourinary Oncology in the UW School of Medicine and Public Health, and Director of Genitourinary Oncology Research and Leader of the Developmental Therapeutics Program at the UW Carbone Cancer Center. Dr. Liu is the chair of the Prostate Cancer subcommittee for ECOG-ACRIN. He is also a co-founder of AIQ Solutions, which is a UW spin-off company based in Madison, WI.

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2000 - 2002
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1997 - 2000
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1997

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1998 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Randomized phase II trial of a DNA vaccine encoding prostatic acid phosphatase (pTVG-HP) versus GM-CSF adjuvant in patients with PSA-recurrent prostate cancer. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Carbone Experts Present Latest Research at World's Largest Cancer Meeting
    Carbone Experts Present Latest Research at World's Largest Cancer MeetingMay 31st, 2019
  • UW Carbone Cancer Center Researchers Win Two National Prostate Cancer Awards
    UW Carbone Cancer Center Researchers Win Two National Prostate Cancer AwardsAugust 24th, 2017
  • Madison Vaccines Announces First Patient Dosed in an Expanded Combination Trial of MVI-816 plus Keytruda® for Metastatic, Treatment-Resistant Prostate Cancer
    Madison Vaccines Announces First Patient Dosed in an Expanded Combination Trial of MVI-816 plus Keytruda® for Metastatic, Treatment-Resistant Prostate CancerAugust 2nd, 2017
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Glenn Liu, Dr. Glenn Liu, MD, Dr. G Liu